Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition
In conclusion, KLK6 inhibition suppressed the proliferation, migration and invasion of gastric cancer cells both in vitro and in vivo through the inhibition of EMT. These findings indicate that KLK6 a potential therapeutic target for gastric cancer therapy.PMID:34055069 | PMC:PMC8145264 | DOI:10.3892/etm.2021.10202
Source: Experimental and Therapeutic Medicine - Category: General Medicine Authors: Dong Zhou Yanping He Hengping Li Weidong Huang Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | General Medicine | Study